Serum Levels of Progranulin Are Closely Associated with Microvascular Complication in Type 2 Diabetes

Disease Markers

Volumn 2015, Issue , 2015, Pages

  Xu, Lin ^a,b   Zhou, Bo ^a   Li, Huixia ^a   Liu, Jiali ^a   Du, Junhui ^a   Zang, Weijin ^a   Wu, Shufang ^a   Sun, Hongzhi ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; GLUCOSE; INSULIN; INTERLEUKIN 6; PROGRANULIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; GRN PROTEIN, HUMAN; SIGNAL PEPTIDE;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FEMALE; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROLIFERATIVE DIABETIC RETINOPATHY; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL; AGED; BLOOD; CASE CONTROL STUDY; COMPLICATION; DIABETIC ANGIOPATHY; MICROVASCULATURE; MIDDLE AGED; PATHOLOGY;

AGED; BIOMARKERS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICROVESSELS; MIDDLE AGED;

EID: 84935898823     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2015/357279     Document Type: Article

References (32)

1. M. Dunlop, "Aldose reductase and the role of the polyol pathway in diabetic nephropathy, " Kidney International, Supplement, vol. 58, no. 77, pp. S3-S12, 2000.
2. J. M. Forbes, V. Thallas, M. C. Thomas, et al., "The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes, " The FASEB Journal, vol. 17, no. 12, pp. 1762-1764, 2003.
3. D. Koya, M. R. Jirousek, Y.-W. Lin, H. Ishii, K. Kuboki, and G. L. King, "Characterization of protein kinase Cα isoform activation on the gene expression of transforming growth factor-β, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats, " Journal of Clinical Investigation, vol. 100, no. 1, pp. 115-126, 1997.
4. E. Galkina and K. Ley, "Leukocyte recruitment and vascular injury in diabetic nephropathy, " Journal of the American Society of Nephrology, vol. 17, no. 2, pp. 368-377, 2006.
5. K.-I. Shikata and H. Makino, "Role of macrophages in the pathogenesis of diabetic nephropathy, " Contributions to Nephrology, vol. 134, pp. 46-54, 2001.
6. F. Chow, E. Ozols, D. J. Nikolic-Paterson, R. C. Atkins, and G. H. Tesch, "Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury, " Kidney International, vol. 65, no. 1, pp. 116-128, 2004.
7. C. G. Ihm, "Monocyte chemotactic peptide-1 in diabetic nephropathy, " Kidney International. Supplement, vol. 60, pp. S20-S22, 1997.
8. F. Y. Chow, D. J. Nikolic-Paterson, E. Ozols, R. C. Atkins, B. J. Rollin, and G. H. Tesch, "Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice, " Kidney International, vol. 69, no. 1, pp. 73-80, 2006.
9. S. Okada, K. Shikata, M. Matsuda, et al., "Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes, " Diabetes, vol. 52, no. 10, pp. 2586-2593, 2003.
10. F. Y. Chow, D. J. Nikolic-Paterson, E. Ozols, R. C. Atkins, and G. H. Tesch, "Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice, " Journal of the American Society of Nephrology, vol. 16, no. 6, pp. 1711-1722, 2005.
11. K. Kaul, A. Hodgkinson, J. M. Tarr, E. M. Kohner, and R. Chibber, "Is inflammation a common retinal-renal-nerve pathogenic link in diabetes?" Current Diabetes Reviews, vol. 6, no. 5, pp. 294-303, 2010.
12. Z. He and A. Bateman, "Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis, " Journal ofMolecularMedicine, vol. 81, no. 10, pp. 600-612, 2003.
13. D. Tolkatchev, S. Malik, A. Vinogradova, et al., "Structure dissection of human progranulin identifies well-folded granulin/epithelin modules with unique functional activities, " Protein Science, vol. 17, no. 4, pp. 711-724, 2008.
14. C. H. P. Ong and A. Bateman, "Progranulin (granulin-epithelin precursor, PC-cell derived growth factor, acrogranin) in proliferation and tumorigenesis, " Histology and Histopathology, vol. 18, no. 4, pp. 1275-1288, 2003.
15. M. B. Jones, M. Spooner, and E. C. Kohn, "The granulinepithelin precursor: a putative new growth factor for ovarian cancer, "GynecologicOncology, vol. 88, no. 1, pp. S136-S139, 2003.
16. G. O. Pizarro, X. C. Zhou, A. Koch, et al., "Prosurvival function of the granulin-epithelin precursor is important in tumor progression and chemoresponse, " International Journal of Cancer, vol. 120, no. 11, pp. 2339-2343, 2007.
17. G. Monami, E. M. Gonzalez, M. Hellman, et al., "Proepithelin promotes migration and invasion of 5637 bladder cancer cells through the activation of ERK1/2 and the formation of a paxillin/FAK/ERK complex, " Cancer Research, vol. 66, no. 14, pp. 7103-7110, 2006.
18. R. R. Guerra, L. Kriazhev, F. J. Hernand ez-Blazquez, and A. Bateman, "Progranulin is a stress-response factor in fibroblasts subjected to hypoxia and acidosis, " Growth Factors, vol. 25, no. 4, pp. 280-285, 2007.
19. J. L. Eriksen and I. R. A. Mackenzie, "Progranulin: normal function and role in neurodegeneration, " Journal of Neurochemistry, vol. 104, no. 2, pp. 287-297, 2008.
20. J. Zhu, C. Nathan, W. Jin, et al., "Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair, " Cell, vol. 111, no. 6, pp. 867-878, 2002.
21. K. Kessenbrock, L. Frohlich, M. Sixt, et al., "Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin, " The Journal of Clinical Investigation, vol. 118, no. 7, pp. 2438-2447, 2008.
22. B. S. Youn, S. I. Bang, N. Kloting, et al., "Serum progranulin concentrations may be associated with macrophage infiltration into omental adipose tissue, " Diabetes, vol. 58, no. 3, pp. 627-636, 2009.
23. A. Tonjes, M. Fasshauer, J. Kratzsch, M. Stumvoll, and M. Bluher, "Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes, " PLoS ONE, vol. 5, no. 11, Article ID e13911, 2010.
24. N. Kloting, M. Fasshauer, A. Dietrich, et al., "Insulin-sensitive obesity, " The American Journal of Physiology: Endocrinology and Metabolism, vol. 299, no. 3, pp. E506-E515, 2010.
25. C.-J. Liu and X. Bosch, "Progranulin: a growth factor, a novel TNFR ligand and a drug target, " Pharmacology and Therapeutics, vol. 133, no. 1, pp. 124-132, 2012.
26. T. Matsubara, A. Mita, K. Minami, et al., "PGRN is a key adipokine mediating high fat diet-induced insulin resistance and obesity through IL-6 in adipose tissue, " Cell Metabolism, vol. 15, no. 1, pp. 38-50, 2012.
27. W. Tang, Y. Lu, Q.-Y. Tian, et al., "The growth factor progranulin binds to tnf receptors and is therapeutic against inflammatory arthritis in mice, " Science, vol. 332, no. 6028, pp. 478-484, 2011.
28. L. Xu, A. Y. Hui, E. Albanis, et al., "Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis, " Gut, vol. 54, no. 1, pp. 142-151, 2005.
29. Z. He, C. H. P. Ong, J. Halper, and A. Bateman, "Progranulin is a mediator of the wound response, " Nature Medicine, vol. 9, no. 2, pp. 225-229, 2003.
30. J. Richter, D. Focke, T. Ebert, et al., "Serumlevels of the adipokine progranulin depend on renal function, " Diabetes Care, vol. 36, no. 2, pp. 410-414, 2013.
31. W. C. Knowler, P. H. Bennett, and E. J. Ballintine, "Increased incidence of retinopathy in diabetics with elevated blood pressure. A six-year follow-up study in Pima Indians, " The New England Journal ofMedicine, vol. 302, no. 12, pp. 645-650, 1980.
32. Y. Yilmaz, F. Eren, O. Yonal, et al., "Serum progranulin as an independent marker of liver fibrosis in patients with biopsyproven nonalcoholic fatty liver disease, " Disease Markers, vol. 31, no. 4, pp. 205-210, 2011.